IMD International Medical Devices has raised funds
July 2023 — IMD International Medical Devices has completed an IPO on the Euronext Growth Milan market, raising a total of US$6.5 million. The funds will be used to strengthen its competitive positioning in the market and implement a growth strategy, both in Italy and abroad.
IMD International Medical Devices designs, develops, manufactures and markets diverse X-ray diagnostic systems as well as components for radiology and medical clinics.
Our role in the transaction
Oaklins Italy’s parent company Banca Akros acted as the Euronext Growth advisor, global coordinator and joint bookrunner in this transaction.
Contacter l'équipe de la transaction
Transactions connexes
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
En apprendre plusSynergia and Bolster have secured acquisition financing for Life & Mobility
Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.
En apprendre plus7BidCo has completed the sell-out procedure for the shares of STAR7
7BidCo S.p.A. has completed the sell-out procedure for 8.5% of STAR7 S.p.A.’s shares.
En apprendre plus